Pegfilgrastim (Neulasta®)
Pronounce: peg-fil-GRAS-tim
Classification: Colony Stimulating Factor
About Pegfilgrastim (Neulasta®)
Pegfilgrastim is a type of colony-stimulating factor. Colony-stimulating factors help your body make more blood cells, including white blood cells, red blood cells, and platelets. Granulocyte colony-stimulating factor (G-CSF) is a protein made by your body to help make more white blood cells. Pegfilgrastim is a long-acting, manmade version of G-CSF that helps your body make more white blood cells, especially a type of white blood cell called a neutrophil. A neutrophil helps your body fight infection. During cancer treatment, your neutrophil levels may be low. When the number of these cells drops below 1000/cubic millimeter (mm3), it is called "neutropenia" or that you are "neutropenic." If you are neutropenic, you are at a higher risk of getting an infection. Pegfilgrastim is used to prevent or treat neutropenia caused by chemotherapy.
Pegfilgrastim is not a cancer treatment, but a supportive care medicine. This means it is used to help your bone marrow make more blood cells during cancer and its treatments.
How to Take Pegfilgrastim
Pegfilgrastim is given as an injection under the skin. This medication also comes as an on-body injector that we talk about in a separate article.
Pegfilgrastim is often given as a single dose for each chemotherapy cycle, no sooner than 24 hours after the last dose of chemotherapy, and no more than 14 days before the beginning of your next chemotherapy cycle.
Storage and Handling
Pegfilgrastim should be refrigerated. This medication should be taken out of the refrigerator 30 minutes before it is due to be given. This can help lessen the sting.
Do not reuse single-dose vials, syringes, or needles. Do not throw the vials, syringes, or needles in household trash. Throw out all used needles and syringes in a puncture-proof disposable container with a lid. The FDA gives more information about the disposal of vials, syringes, and needles. Keep the vials out of the reach of children.
Where do I get this medication?
Depending on your insurance coverage, pegfilgrastim may be administered in your provider’s office or provided through home infusion or a specialty pharmacy. Your provider will work with your major medical and prescription drug plans and tell you where you should receive this medication.
Insurance Information
This medication may be covered by your prescription plan. If you qualify, you may be able to get financial help through patient assistance programs (PAP). Co-pay cards may also be available to lower your out-of-pocket cost if you have commercial (not Medicare/Medicaid/Tricare) insurance. Your pharmacist, social worker, or navigator can help find resources for financial support.
Possible Side Effects
These are some of the most common or most serious side effects of this medication. Talk with your provider about the side effects you are having and how they can be managed.
Bone, Joint, and Muscle Pain
This medication can cause severe bone, joint, and/or muscle pain. This can happen when you start the medication to a few months after. Tell your providers about your symptoms and they can give you ways to relieve pain. If you have pain in your hip, thigh, and groin, it can be an atypical femur fracture. This is a type of fracture that is caused by certain medications. Tell your providers right away about any new pain in this area.
Irritation or Burning at the Injection Site
Some people experience redness, swelling, or itching at the site of injection. This is usually temporary. The injection can sting or burn if it is given when it is cold. Take the medication out of the refrigerator 30 minutes ahead of time to let it come to room temperature before it is given.
Important but Less Common Side Effects
Spleen Rupture
Your provider will monitor you for an enlarged spleen or rupture while using this medication. If you have pain on the left side of your abdomen (belly) or your shoulder after receiving pegfilgrastim, call your provider right away.
Acute Respiratory Distress Syndrome (ARDS)/Alveolar Hemorrhage
This medication can cause a series lung problems called acute respiratory distress syndrome. If you experience shortness of breath, fever, breathing trouble, or a fast rate of breathing, contact your healthcare team or go to the emergency room.
Allergic Reactions
Some people may have an allergic reaction to this medication. Signs of an allergic reaction are:
- Shortness of breath or trouble breathing.
- Chest pain.
- Rash.
- Itching.
- Flushing (reddening of the skin, often on the face, neck, or chest).
- A drop in blood pressure (you may feel lightheaded, dizzy, or weak).
If you have any of these signs while you are getting an infusion, tell your provider right away. The infusion will be slowed down or stopped. Depending on your reaction, you may still be able to get the medication if you are given medicine to prevent a reaction or if the medication is given at a slower rate.
Sickle Cell Crisis
In patients with sickle cell anemia, pegfilgrastim can cause a sickle cell crisis. Call your provider right away if you have symptoms of a sickle cell crisis, such as pain and trouble breathing.
Kidney Problems
This medication can cause kidney problems, like an increased creatinine level. Your provider may monitor for kidney problems with blood tests. Symptoms may be:
- Less urine output than normal.
- Blood in the urine.
- Swelling in the ankles.
- Loss of appetite.
Tell your provider if you have any of these symptoms.
Capillary Leak Syndrome
Capillary leak syndrome is when blood and parts of your blood leak out of your blood vessels and into your muscles and open spaces in your body. This can cause low blood pressure (hypotension) and can stop your organs from working correctly. Symptoms may be:
- A sudden drop in blood pressure.
- Weakness.
- Fatigue.
- Sudden swelling of the arms, legs, or other parts of the body.
- Nausea.
- Lightheadedness.
If you have any of these symptoms, tell your provider right away.
Aortitis
This medication can make your aorta (the largest artery in your body) inflamed (swollen, which can occur as early as the first week of starting treatment with filgrastim. Sign of aortitis include fever, abdominal pain, fatigue, and back pain. Be sure to call your provider right away if you are experiencing any of these symptoms.
Low Platelet Count (Thrombocytopenia)
Platelets are blood cells that help your blood clot. Thrombocytopenia is when your platelet count is lower than normal, and you are at a higher risk of bleeding. Tell your providers if you have any bruising or bleeding, including nose bleeds, bleeding gums, or blood in your urine or stool. If your count gets too low, you may receive platelets from a donor.
- Do not use a razor (an electric razor is fine).
- Do not do activities that can cause injury or bleeding.
- Talk to your provider before taking any non-steroidal, anti-inflammatory medications (NSAIDs) like Motrin/Advil (ibuprofen), Aleve (naproxen), Celebrex (celecoxib), and others. These can raise the risk of bleeding.
- Use a soft-bristle toothbrush to brush your teeth. Ask your provider about flossing or using toothpicks.
Secondary Cancers
A secondary cancer happens as a result of cancer treatment for another cancer. This is rare, but you should know your risk. Secondary cancers can be related to chemotherapy and other anti-cancer medications. Often, a secondary cancer is a blood cancer. This can happen years after treatment and is often related to repeated treatments or high doses. Your provider will watch your labs closely. They may suggest you have a blood test called a complete blood count with differential. This is often done each year if you had high risk therapies.
Reproductive Concerns
Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or have a child while on this medication. Effective birth control is necessary during treatment. Even if your menstrual cycle stops or you believe you are not producing sperm, you could still be fertile and conceive. You should consult with your provider before breastfeeding while receiving this medication.
Current Biosimilars
There are biosimilar versions of pegfilgrastim. A biosimilar is a medication that has been approved by the FDA because it is very similar to an FDA-approved medication (called a reference product, or the medication it is being compared to), and that there are no meaningful differences between the biosimilar product and the reference product. These medications may be used interchangeably.
The biosimilar versions of this medication include pegfilgrastim-jmdb (Fulphila®), pegfilgrastim-cbqv (Udenyca®) and pegfilgrastim-bmez (Ziextenzo™).